Filing Details
- Accession Number:
- 0001179110-20-000621
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-16 17:14:58
- Reporting Period:
- 2020-01-14
- Accepted Time:
- 2020-01-16 17:14:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755174 | Ann Jo Beltramello | C/O Momenta Pharmaceuticals, Inc. 301 Binney St, Cambridge MA 02142 | Chief Hr And Inf. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Commonstock | Acquisiton | 2020-01-14 | 2,362 | $10.83 | 46,078 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-14 | 30,800 | $12.58 | 76,878 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-14 | 36,485 | $13.02 | 113,363 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-14 | 25,495 | $13.26 | 138,858 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-14 | 26,183 | $15.44 | 165,041 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-14 | 2,362 | $21.35 | 162,679 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-14 | 30,800 | $22.58 | 131,879 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-14 | 36,485 | $23.02 | 95,394 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-14 | 25,495 | $23.26 | 69,899 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-14 | 26,183 | $25.44 | 43,716 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-14 | 1,264 | $20.47 | 42,452 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 1,493 | $0.00 | 1,493 | $10.83 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 869 | $0.00 | 869 | $10.83 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 11,240 | $0.00 | 11,240 | $13.26 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 14,255 | $0.00 | 14,255 | $13.26 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 22,935 | $0.00 | 22,935 | $12.58 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 7,895 | $0.00 | 7,895 | $12.58 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 36,485 | $0.00 | 36,485 | $13.02 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 19,357 | $0.00 | 19,357 | $15.44 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 6,826 | $0.00 | 6,826 | $15.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,843 | 2019-02-09 | 2026-02-09 | No | 4 | M | Direct |
| 28,595 | 2017-02-09 | 2026-02-09 | No | 4 | M | Direct |
| 0 | 2015-02-22 | 2021-02-22 | No | 4 | M | Direct |
| 0 | 2013-11-22 | 2021-02-22 | No | 4 | M | Direct |
| 0 | 2016-11-19 | 2023-02-19 | No | 4 | M | Direct |
| 0 | 2017-02-19 | 2023-02-19 | No | 4 | M | Direct |
| 0 | 2018-11-18 | 2025-02-18 | No | 4 | M | Direct |
| 0 | 2015-11-14 | 2022-02-14 | No | 4 | M | Direct |
| 0 | 2016-02-14 | 2022-02-14 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the person on November 7, 2019.
- This transaction was executed in multiple trades at prices ranging from $21.34 to $21.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.
Billionaire Hedge Funds
